Viewing Study NCT00755534


Ignite Creation Date: 2025-12-25 @ 2:25 AM
Ignite Modification Date: 2025-12-27 @ 9:48 AM
Study NCT ID: NCT00755534
Status: TERMINATED
Last Update Posted: 2013-02-13
First Post: 2008-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC
Sponsor: Hellenic Oncology Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module